The Delisting Wave: From NYSE to the OTC Graveyard
There's a final indignity waiting for failed SPAC companies: delisting. When a stock falls below $1.00 for 30 consecutive trading days, major exchanges issue a deficiency notice. The company has 180 days to get back above $1. Most can't. They get booted to the OTC markets — a shadow exchange where liquidity evaporates, institutional investors are barred from holding shares, and the stock quietly dies in obscurity.
The Mechanics of Delisting
NYSE and Nasdaq both require listed companies to maintain a minimum share price of $1.00. When a stock trades below that threshold for 30 consecutive days, the exchange sends a formal deficiency notice. The company then has a compliance window — typically 180 days — to regain the $1 level for at least 10 consecutive trading days. If it fails, trading is suspended and the stock is moved to the OTC (over-the-counter) markets.
For de-SPAC companies, this process became almost routine by 2023. Stocks that merged at $10 and fell to $2, then $0.50, then $0.15 had no realistic path back to $1 without drastic action. The most common escape hatch: a reverse stock split. But that brought its own problems.
The reverse split death sentence: A 1-for-20 reverse split turns a $0.50 stock into a $10 stock — on paper. But the market sees through it. Studies show that stocks executing reverse splits to avoid delisting lose an additional 30-50% within six months. The split signals desperation, and investors run.
The Delisting Timeline
| Year | De-SPAC Delisting Notices | Actually Delisted | Reverse Splits to Avoid Delisting |
|---|---|---|---|
| 2022 | 28 | 8 | 12 |
| 2023 | 87 | 41 | 38 |
| 2024 | 112 | 73 | 52 |
| 2025 (est.) | 65 | 48 | 30 |
Life on the OTC Markets
Once delisted, a stock moves to OTC Markets Group — specifically the OTC Pink Sheets, the lowest tier. Trading volume collapses by 80-95%. Bid-ask spreads widen to 20-50% of the stock price. Many brokerages restrict or prohibit trading in OTC Pink Sheet stocks, effectively trapping remaining shareholders.
For the companies, delisting triggers a cascade: institutional investors must sell (most fund mandates prohibit OTC holdings), index funds must sell, ETFs must sell. The forced selling creates a final wave of selling pressure that pushes already-decimated stocks even lower. Companies that were trading at $0.30 pre-delisting often settle at $0.02-0.05 on the OTC markets.
The Shame Spiral
Delisting carries reputational consequences beyond the stock price. Companies lose analyst coverage (if they had any left). Press releases go unread. Recruiting becomes nearly impossible — who wants to join a company trading on the Pink Sheets? Partners and customers question viability. It's a corporate death spiral that mirrors the de-SPAC death spiral that got them here.
The zombie roster:As of early 2026, over 120 former SPAC companies trade on OTC markets with market caps under $10 million — companies that were valued at $500M-$5B at merger. They're technically alive but functionally dead: no capital, no coverage, no path forward. They exist in a corporate purgatory, burning through whatever cash remains while waiting for the inevitable bankruptcy filing or quiet dissolution.
Notable Delistings
| Company | SPAC Merger Valuation | Price at Delisting | Current OTC Price |
|---|---|---|---|
| Hyzon Motors | $2.1B | $0.38 | $0.02 |
| IronNet Cybersecurity | $1.2B | $0.28 | Bankrupt |
| View Inc. | $1.6B | $0.15 | $0.01 |
| Electric Last Mile | $1.4B | Halted | Bankrupt |
| Embark Technology | $5.2B | $0.22 | Dissolved |
| Bird Global | $2.3B | $0.08 | Bankrupt |
| Enjoy Technology | $1.2B | $0.12 | Bankrupt |
These weren't penny stocks that snuck onto exchanges. They were billion-dollar companies backed by major investment banks, promoted on national television, and purchased by hundreds of thousands of retail investors. Now they trade for less than a pack of gum.
Delisting data from NYSE/Nasdaq regulatory filings, OTC Markets Group, and SPACGraveyard tracking. Updated March 2026.